Clinical Trials Logo

Clinical Trial Summary

This study will attempt to identify the specific gene (coded in the DNA) and changes (mutations) within that gene that are the cause of monogenic kidney stone disease. This study will help researchers determine the characteristics of the stone disease associated with specific genes and mutations. This information may help develop more effective treatments for monogenic kidney stone diseases.


Clinical Trial Description

Have a blood test (about 2 teaspoons; ½ to 1 teaspoons for children) or buccal cell collection for DNA or RNA isolation • Complete a kidney stone history questionnaire In addition to the above testing, family members may be asked to participate in the following: • Complete a 24 hr. urine collection Your samples will undergo genetic testing. We will share the results with your local doctor. All family members, of a patient whose genetic testing showed no known mutations, will not be tested. These samples will be stored for future research. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03305835
Study type Observational
Source Mayo Clinic
Contact RKSC Study Coordinators
Phone 800-270-4637
Email RareKidneyStones@mayo.edu
Status Recruiting
Phase
Start date September 11, 2017
Completion date February 2028